Beginning Cash: The amount of cash reported by the company on its previous statement.
Sonoma Pharmaceuticals, Inc. (SNOA) had Beginning Cash of $2.40M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$7.17M |
|
$-0.07M |
|
$4.37M |
|
$2.81M |
|
$6.88M |
|
$0.29M |
|
$0.09M |
|
$0.38M |
|
$0.38M |
|
$-0.07M |
|
$-0.07M |
|
$-0.07M |
|
$-0.07M |
|
$0.29M |
|
$0.32M |
|
4.91M |
|
4.91M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$15.34M |
|
$0.29M |
|
$1.76M |
|
$17.10M |
|
$4.42M |
|
-- |
|
$6.07M |
|
$10.49M |
|
$6.61M |
|
$6.61M |
|
$6.61M |
|
5.06M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
$-0.04M |
|
$3.69M |
|
|
Beginning Cash |
$2.40M |
$4.61M |
|
$2.21M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.48 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
39.13% |
|
4.04% |
|
4.04% |
|
-- |
|
5.32% |
|
-0.92% |
|
$-1.43M |
|
-- |
|
-- |
|
-- |
|
0.42 |
|
1.24 |
|
2.00 |
|
44.94 |
|
-1.00% |
|
-1.00% |
|
-0.39% |
|
-1.00% |
|
$1.31 |
|
$-0.29 |
|
$-0.28 |
|